Leadership Transition at lifespin

Effective October 1, lifespin CEO Dr. Ali Tinazli transitioned from his executive role while remaining closely connected to the company as a member of the company’s Scientific & Strategic Advisory Board.

During his tenure, Dr. Tinazli led lifespin through a significant phase of development – from a research-driven organization to an AI-driven health technology company with an established commercial platform, international partnerships, and a growing presence across global healthcare markets.

The company’s existing management team, Dr. Sonja Wiedemann and Dr. Roland Geyer, will continue to lead the business, ensuring continuity while advancing lifespin’s next phase of growth and development.

We would like to thank Dr. Tinazli for his leadership, commitment, and contribution to the company’s development over the past five years. We are pleased that lifespin will continue to benefit from his experience and perspective through his role on the Scientific & Strategic Advisory Board.

lifespin enters this next chapter with a strong foundation, a clear strategic direction, and continued commitment to advancing data-driven healthcare and precision diagnostics.